Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
47.84
+0.11 (+0.23%)
Streaming Delayed Price
Updated: 10:44 AM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
311,753
Open
47.48
Bid (Size)
47.85 (2,600)
Ask (Size)
47.88 (400)
Prev. Close
47.73
Today's Range
47.29 - 47.85
52wk Range
43.32 - 55.77
Shares Outstanding
1,250,690,553
Dividend Yield
4.62%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
March 31, 2026
In a move that signals a decisive shift in the treatment of chronic autoimmune conditions, Gilead Sciences (NASDAQ:GILD) announced on March 23, 2026, its definitive agreement to acquire Ouro Medicines...
Via
MarketMinute
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
As of March 31, 2026, Moderna Inc. (NASDAQ: MRNA) finds itself at a defining historical junction. After years of being defined by a single, world-altering product—its COVID-19 vaccine—the...
Via
Finterra
Topics
Initial Public Offering
Performance
YTD
-0.8%
-0.8%
1 Month
+0.4%
+0.4%
3 Month
-1.3%
-1.3%
6 Month
-3.9%
-3.9%
1 Year
-12.0%
-12.0%
More News
Read More
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
Sanofi ADR (NASDAQ:SNY) Presents a Classic Value Investment Case
↗
March 25, 2026
Via
Chartmill
AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
March 27, 2026
Via
MarketMinute
Topics
Intellectual Property
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
March 26, 2026
Via
MarketMinute
The Brain Barrier Broken: Inside Denali Therapeutics’ Landmark FDA Approval of AVLAYAH
March 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Sanofi (NASDAQ:SNY) Emerges as a Top Dividend Stock from Methodical Screening
↗
March 11, 2026
Via
Chartmill
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
March 24, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
↗
March 20, 2026
Via
The Motley Fool
The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
March 16, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Initial Public Offering
Stocks
Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
March 12, 2026
Via
Finterra
Topics
Economy
DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch
↗
March 09, 2026
Via
Stocktwits
The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology
March 06, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
The Best Healthcare Stock to Invest $1,000 in Right Now
↗
March 02, 2026
Via
The Motley Fool
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
February 27, 2026
Via
Finterra
Topics
Economy
AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange
February 26, 2026
Via
MarketMinute
Topics
ETFs
European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO
February 23, 2026
Via
MarketMinute
Topics
Intellectual Property
1 No-Brainer Biotech Stock To Buy Today and Never Sell
↗
February 21, 2026
Via
The Motley Fool
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
February 17, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom
February 16, 2026
Via
MarketMinute
Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance
February 12, 2026
Via
Finterra
Topics
Economy
Intellectual Property
FDA Stuns Moderna with Refusal to Review Flu Vaccine, Sending Shares Tumbling 3.5%
February 12, 2026
Via
MarketMinute
Topics
Earnings
This Infrastructure Stock Surged Nearly 40% in One Year -- and One Fund Sold $11 Million in Shares
↗
January 29, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences
January 28, 2026
Via
MarketMinute
Frequently Asked Questions
Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 47.84
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 04/02/26 10:44 AM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 59.83B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 60B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.